AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)
UkraineAll drugs from this manufacturer
-
The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It is also used to reduce the risk of hospitalization due to heart failure in patients with established cardiovascular disease or risk factors.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage dapagliflozin 10 mg metformin 1000 mg ATC: A10BD15
-
The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It also helps to reduce the risk of hospitalization due to heart failure in patients with type 2 diabetes and established cardiovascular disease or risk factors.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage dapagliflozin 5 mg metformin 1000 mg ATC: A10BD15
-
The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It is also used to reduce the risk of hospitalization due to heart failure in patients with type 2 diabetes and established cardiovascular disease or risk factors.
Dosage form: tablets, film-coated, prolonged release
Active substance Dosage dapagliflozin 10 mg metformin 500 mg ATC: A10BD15